Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
>99
EC/CAS
247-500-7]and/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0.003
EC/CAS
247-500-7
Name of the chemical
Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one
Concentration
<0.003
EC/CAS
220-239-6
Name of the chemical
Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one 2-Methyl-2H-isothiazol-3-one
Concentration
0.06%<
General Information
Version
19
Revision date
2023-11-21
Product name
ImmunoCAP Specific IgG/IgG4 Control L
Emergency telephone
+(353)-19014670, +(32)-28083237
Icons in SDS
Company Information
company name
Phadia AB
e-mail address of the competent person responsible for the Safety Data Sheet
safetydatasheet.idd@thermofisher.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Physical hazards
Based on available data, the classification criteria are not met
Health hazards
Skin Sensitization Category 1
Environmental hazards
Based on available data, the classification criteria are not met Chronic aquatic toxicity Category 3 For the full text of the H-statements mentioned in this Section, see Section 16.
Signal word
Warning H317 - May cause an allergic skin reaction H412 - Harmful to aquatic life with long lasting effects P273 - Avoid release to the environment P280 - Wear protective gloves/protective clothing P501 - Dispose of contents/container in accordance with local, regional, national and international regulations.
2.3 Other hazards
This product contains human sourced material. The donors have been tested and found to be non-reactive for HBsAg, HIV-1 Ag, anti-HCV and anti HIV-1/HIV-2. This product does not contain any known or suspected endocrine disruptors. This preparation contains no substance considered to be persistent, bioaccumulating nor toxic (PBT). This preparation contains no substance considered to be very persistent nor very bioaccumulating (vPvB).
